Number of new cases of cervix uteri cancer

Albania

Ministry of Health.

Armenia

Source of data: National Health Information Analytic Center, Ministry of Health of the Republic of
Armenia http://moh.am/?section=static_pages/index&id=625&subID=824,29.
Data collected annually, reference period: 31 December.
Note: The low number of new cases in 2014 is due to low number of women who had been screened for
cervix uteri cancer. In order to detect cervical cancer in early stage, and increase coverage of
women, a new programme for Pap smear screening started for women aged from 30 to 59 years in
January 2015, with the support of the World Bank (in the framework of public procurement).

Austria

Source: Statistics Austria, Austrian Cancer Registry.

Belgium

Data source: National Cancer Registry (http://www.kankerregister.org/). Data before the year 2004
were incomplete and should be used with caution.

Bosnia and Herzegovina

Public Health Institute - National cancer register (NCR) for 1986,1987, 1988 and 1989. Available for
years 1987, 1988,1989. Source: NCR war period. There are no selected data. Public Health Institute
of Federation of B&H; Department for Health Statistics and Informatics Public Health Institute of
Republic of Srpska. Department for social medicine with health organization and health economics.
Law on Health Evidence and Statistical Research in Health. Annual report of health facilities
Department for Health of Brcko District.

Cyprus

There is an on-going process of revision of cancer registry data. Cases identified by Death
Certificate Only are also included in all years (1998-2007).

Czechia

Source: Czech National Cancer Registry.

Denmark

Source: The Cancer Registry, The Danish Health Data Authority.

Estonia

Source: Estonian Cancer Registry, National Institute for Health Development.
Data have been updated on the basis of the registry?s database in January 2016.

Finland

Source: Finnish Cancer Registry, Cancer Society of Finland based on agreement with THL (National
Institute for Health and Welfare).
Source: Cancer Register, THL (National Institute for Health and Welfare) / Cancer Organizations.

France

Source of data: Institut national du cancer estimation nationale de l?incidence et de la mortalite
par cancer en France entre 1980 et 2012

Georgia

Source: National Centre for Disease Control and Public Health of Georgia (NCDC) (http://www.ncdc.ge)

Germany

Source: Robert Koch-Institute - German Centre for Cancer Registry Data (ZfKD)
http://www.krebsdaten.de or http://www.rki.de
Coverage: Data contain the estimated number of all newly diagnosed cancer cases in Germany coded
with ICD-10 C53 (Malignant neoplasm of cervix uteri) during the given calendar year.
Estimation method: The population-based cancer registries in each German federal state transfer data
to the German Centre for Cancer Registry Data (ZfKD), as required by the Federal Cancer Registry
Data Act (Bundeskrebsregisterdatengesetz). These data are combined, quality-checked, analysed and
evaluated.
At the moment reliable data on cancer incidence and survival are not available for all federal
states. Therefore, the ZfKD estimates new diagnosis, prevalence and survival rates for Germany in
addition to estimating the completeness of data capture in the individual registries. The basic
principle is that the data are first checked for registration completeness and, upon meeting
pre-defined criteria, are then used for the calculation of the various statistics.
The value of population-based cancer data vitally depends on the completeness of the capture of all
newly diagnosed cancer cases. Since 2009 in all federal states there has been comprehensive
geographical epidemiological cancer registration and great advances have been achieved. But the
situation in the individual states is very heterogeneous: continuous, state-wide registration was
commenced between 1967 (Saarland) and 2009 (Baden-Wurttemberg). The ZfKD consequently regularly
estimates the degree of completeness for the population-based cancer registries.
The basis for this evaluation is the ratio of incidence to mortality (M/I-Index), an internationally
commonly used indicator. It is assumed here that diagnosis and survival prospects of cancer patients
within Germany do not differ fundamentally and that regionally differing cancer risks can thus be
approximated by official cause of death statistics. Using the M/I-Index of a reference registry that
has been assessed as being complete along with the cancer mortality at a region whose completeness
is to be assessed, it is possible to estimate the expected cancer incidence in that region and
compare it with the number of cases actually registered.
According to the current evaluation, for the year 2012, twelve federal states have already reached
an estimated completeness level of at least 90%, seven federal states have reached over 95%
completeness.
Using the data of the epidemiological cancer registries in Germany as a basis, the ZfKD estimates
the number of all newly diagnosed cancer cases each year. The results of the completeness assessment
form the basis of this estimation. The annual number of incident cases for each localization arises
from the summation of the cases from the ?complete? registries (estimated capture rate of at least
90%) and the expected incidence from the completeness assessment for those federal states that are
either deemed to be incomplete or for which no data is available.
Break in time series: The modification of the procedure to estimate completeness required the
adaption of the methods for estimating incidence. One of the requirements places on the new method
was to enable a smooth transition from ?estimating? to ?counting? the annual number of incident
cases in Germany while continuing to allow an assessment of trends over time. Since the new methods
of estimation for both completeness and incidence can only be used in this form from 1999 onwards,
the results of earlier estimates are not directly comparable to the current ones for methodological
reasons.

Greece

Data are not available.

Hungary

Source: National Cancer Register.
Note: Benign tumours are rarely registered in the NCR. Some data from 1999 were recorded as year
2000. Correction of the data has only partially taken place. Therefore, there is a higher case
number in 2000. Data for the number of metastatic tumours with codes C77-C79 have been left out.

Iceland

Source: The Icelandic Cancer Registry.
Note: From 2002, the data is shown as a 3-year average in order to minimize the random fluctuations
due to the few inhabitants of Iceland.

Ireland

Source: National Cancer Registry. Figures for the latest year are incomplete and should be
considered provisional.

Israel

Source: Israel Cancer Registry, Ministry of Health.

Italy

It is estimated by means of specific epidemiological studies. Source: Istituto Superiore di Sanita
Centro Nazionale di Epidemiologia Sorveglianza e Prevenzione della Salute (CNESPS). Estimates were
obtained with the MIAMOD methodology using cancer-specific data on mortality 1980-2002 (Official
National Statistics - ISTAT) and survival of patients diagnosed in 1985-2002 (Italian Network of
Cancer Registries - AIRTUM). Official mortality data were corrected to include cervical cancer
deaths classified as uterus NOS. The MIAMOD method has been applied to obtain forecasts from 2003
onwards . All estimates are referred to age group 0-94 years. The estimates were obtained separately
for the 20 Italian regions. National estimates were derived by summing up the regional estimates.
For further details see: Rossi S, Capocaccia R, De Angelis R and Gatta G (Eds). Cancer Burden in
Italian Regions. Tumori 2013; 99 (3): pp. 269-439

Kyrgyzstan

Note: Increase in the number of reported cases of cervical cancer in 2009 is due to conducting
professional examinations in 2 regions of the country (Naryn and Osh).

Latvia

Source of data: Up to 2002 the data source was the annual statistical report. Starting from 2003 the
data source is the Register of Patients with Particular Diseases.

Lithuania

Source: National Cancer Register.

Luxembourg

Registre morphologique des tumeurs. Laboratoire national de sante, Divisions d'anatomie
pathologique, de cytologie clinique et d'hematologie. Annual report edited by the association
\Registre morphologique des tumeurs au Grand-Duche

Malta

Source: Department of Health Information and Research, Malta National Cancer Registry which use the
Pathology labs., Autopsy reports, National Mortality Register and Notification.

Montenegro

Source: Institute of Public Health based on National Population Cancer Registry (see ind. No
991051).

Netherlands

Source of data: National Cancer Centre: Netherlands Cancer Registry.

North Macedonia

Source: Cancer registry, Institute for Public Health (IPH).

Poland

Source of data: National Cancer Registry - Institute of Oncology.

Portugal

Source of data: Ministry of Health ? National Cancer Registry Coverage: National

Romania

Source: The number of new cases of cancer are reported by each district?s oncological cabinet to
National Center for Statistics and Informatics in Public Health.
Break in time series:
2014: since year 2014, data from private sector included.

Serbia

Source of data: Institute of Public Health of Serbia, National Cancer Registry.
Coverage: complete from 2007 onwards. Up to 2007 data do not cover one NUTS level-2 Region
(Vojvodina) that is approximately 30% of population (according Census 2011 data). Decreasing of
number of new cases starting from 2012 onwards indicates underreporting by health institutions.

Slovakia

Source: National Cancer Registry of Slovakia (ICD10 codes used).

Slovenia

Source of data: Cancer Registry of Republic of Slovenia, Institute of Oncology Ljubljana, March
2016.
Methodology (definition): Number of all newly diagnosed cervical cancers (ICD-9: 180; ICD-10: C53)
during the given calendar year.

Sweden

Source of data: National Board of Health and Welfare (NBHW)
The Swedish Cancer Register (NBHW)
Online Database: http://www.socialstyrelsen.se/statistics/statisticaldatabase/cancerÿ

See the general documentation for variable 991051.
Icd7: 171 Cervix uteri

Switzerland

Source of data: Estimation for Switzerland from the National Institute for Epidemiology and Cancer
Registration (NICER) based on the Cancer Registries of Geneva (since 1970), Vaud and Neuchatel
(since 1974), Zurich (1980-2011), St. Gallen-Appenzell (since 1980), Basel-Stadt and
Basel-Landschaft (1981-2009), Valais and Graubunden (since 1989), Glarus (Since 1992), Ticino (Since
1996), Jura (since 2005), Fribourg (since 2006), Lucerne (since 2010), Nidwalden, Obwalden, Uri and
Zug (since 2011).
Coverage: extrapolation based on registered areas covering from 41% of the population in 1980 to 65%
in 2012.
Deviation from the definition:
Estimation method: The extrapolation is based on language regions, for detailed information please
refer to the Federal Statistical Office?s Cancer Epidemiology website.
(http://www.bfs.admin.ch/bfs/portal/en/index/infothek/erhebungen__quellen/blank/blank/kbs/02.html)
-.

Türkiye

Source of data: Public Health Institution of Turkey, Ministry of Health of Turkey.

Turkmenistan

Source of data: Administrative medical statistics, forms: 7 ?Report on the incidence of and patients
with cancer?, 5 ?Report on morbidity?, 025-2/y ?Statistical card? and 090-1/y ?Notification of
patients with newly diagnosed malignancy?.
Note: The increase in the number of new cases of cervical cancer in year 2013 is due to a screening
program for early detection of cancer that took place in the country from November 1 2013 till
January 1 2014.

Ukraine

Source: Centre of Health Statistics, Ministry of Health.

United Kingdom

Source of Data: England - Office for National Statistics, Cancer Registry.
Northern Ireland - Northern Ireland Cancer Registry.
Scotland - Scottish Cancer Registry, NHS National Services Scotland, Information Services Division
(ISD).
Wales - Welsh Cancer Intelligence and Surveillance Unit.
Coverage: (In October 2013) The data has been changed from 2000 onwards as this is more up to date
and is our policy to continually update if it is more accurate.
Deviation from the Definition: None
Break in Time Series:
In 2009, the increase could be due to the death of a young celebrity from cervical cancer in 2009,
which led to more awareness among young females and improved levels of screening, resulting in more
cases being diagnosed.
2010 - All data is financial year data with the exception of Scotland and Northern Ireland whose
data is calendar year.
Estimate: 2014 data from Scotland is unavailable so the 2013 figure has been used as an estimate